Nektar Therapeutics Reports First Quarter 2021 Financial Results

SAN FRANCISCO , May 6, 2021 /PRNewswire/ —  Nektar Therapeutics  (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2021 .     Cash and investments in marketable securities at March 31, 2021 were approximately $1.1 billion as compared to $1.2 billion at December

close

Get every new post delivered right to your inbox.

Original Source